Clinical trials
Completed Blood Coagulation Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 85 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Swedish Orphan Biovitrum | 7 |
| BioMarin Pharmaceutical | 5 |
| Bayer | 3 |
| Spark Therapeutics, Inc. | 3 |
| CSL Behring | 2 |
| Genzyme, a Sanofi Company | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Novartis Pharmaceuticals | 2 |
| Seagen Inc. | 2 |
| Seoul National University Bundang Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blood Coagulation Disorders | 85 |
| Hematologic Diseases | 24 |
| Hemorrhagic Disorders | 24 |
| Hemophilia A | 21 |
| Coagulation Protein Disorders | 18 |
| Genetic Diseases, Inborn | 15 |
| Hemostatic Disorders | 12 |
| Blood Coagulation Disorders, Inherited | 11 |
| Hemophilia B | 9 |
| Hemorrhage | 9 |
Trials
Showing 76 to 85 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.